Related Experiment Video
Updated: Jun 18, 2026

Measuring Composition of CD95 Death-Inducing Signaling Complex and Processing of Procaspase-8 in this Complex
Published on: August 2, 2021
Playing the DISC: turning on TRAIL death receptor-mediated apoptosis in cancer
Bodvaël Pennarun1, Annemieke Meijer, Elisabeth G E de Vries
1Department of Medical Oncology, University Medical Center Groningen, Groningen, The Netherlands.
Abstract:
Formation of the pro-apoptotic death-inducing signaling complex (DISC) can be initiated in cancer cells via binding of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to its two pro-apoptotic receptors, TRAIL receptor 1 (TRAIL-R1) and TRAIL-R2. Primary components of the DISC are trimerized TRAIL-R1/-R2, FADD, caspase 8 and caspase 10. The anti-apoptotic protein FLIP can also be recruited to the DISC to replace caspase 8 and form an inactive complex. Caspase 8/10 processing at the DISC triggers the caspase cascade, which eventually leads to apoptotic cell death. Besides TRAIL, TRAIL-R1- or TRAIL-R2-selective variants of TRAIL and agonistic antibodies have been designed. These ligands are of interest as anti-cancer agents since they selectively kill tumor cells. To increase tumor sensitivity to TRAIL death receptor-mediated apoptosis and to overcome drug resistance, TRAIL receptor ligands have already been combined with various therapies in preclinical models. In this review, we discuss factors influencing the initial steps of the TRAIL apoptosis signaling pathway, focusing on mechanisms modulating DISC assembly and caspase activation at the DISC. These insights will direct rational design of drug combinations with TRAIL receptor ligands to maximize DISC signaling.
Insights
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers cancer cell death by forming the death-inducing signaling complex (DISC). Understanding DISC assembly and caspase activation is key to developing effective TRAIL-based cancer therapies.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The death-inducing signaling complex (DISC) formation is initiated by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) binding to its receptors TRAIL-R1 and TRAIL-R2 on cancer cells.
- Key DISC components include trimerized TRAIL-R1/-R2, FADD, caspase 8, and caspase 10, with FLIP potentially inhibiting apoptosis.
- Caspase 8/10 activation at the DISC initiates a cascade leading to programmed cell death.
Purpose of the Study:
- To review factors influencing TRAIL-mediated apoptosis signaling pathway initiation.
- To focus on mechanisms modulating DISC assembly and caspase activation.
- To guide the rational design of combination therapies involving TRAIL receptor ligands.
Main Methods:
- Literature review of TRAIL-mediated apoptosis.
- Analysis of DISC formation and caspase activation mechanisms.
- Discussion of preclinical combination therapy models.
Main Results:
- TRAIL receptor ligands, including selective variants and agonistic antibodies, are investigated as anti-cancer agents.
- TRAIL receptor ligands show potential in selectively killing tumor cells.
- Combination therapies are explored to enhance tumor sensitivity and overcome drug resistance.
Conclusions:
- Insights into DISC assembly and caspase activation are crucial for optimizing TRAIL-based cancer treatments.
- Understanding these mechanisms can lead to improved drug combinations for enhanced anti-cancer efficacy.
- Targeting DISC signaling offers a promising strategy for developing novel cancer therapies.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Apoptosis
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
